Skip to main content
    O

    Onconetix Inc (ONCO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.00
    +0.09 (+3.09%)

    Market Cap: $2.15M

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Onconetix Inc (ONCO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Onconetix (ONCO) has a market cap of $2.15M. It holds $2.64M more cash than debt, 122.86% of its market cap.

    Total Valuation

    Market Cap$2.15M
    Latest price (Nov 17, 2026)$3.00

    Key Dates

    The next earnings report is expected on Nov 17, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 17, 2026 (expected)
    Last Earnings DateAug 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 85.54% in the quarter ended Sep 30, 2026.

    Shares Outstanding416.12K
    Shares Change (QoQ)+85.54%

    Price Statistics

    The stock is down 99.74% over 52 weeks and trades 49.92% below its 50-day average.

    Beta (1Y)1.21
    52-Week Change-99.74%
    1-Month Change-30.28%
    3-Month Change-57.81%
    6-Month Change-74.47%
    Total Return (1Y)-99.74%
    Total Return (3Y CAGR)-98.27%
    Return vs SPY (1Y)-111.32%
    Max Drawdown (1Y)-99.81%
    Max Drawdown (3Y)-100.00%
    Sharpe Ratio (1Y)-2.97
    Correlation with SPY (1Y)0.08
    50-Day Average$5.99
    200-Day Average$92.70
    52-Week Range$2.76 to $1,610.00
    RSI (14 Days)38.3
    Average Volume (20 Days)3.20M

    Price chart

    Financial Position

    Current assets cover 1.47x current liabilities.

    Current Ratio1.47x
    Quick Ratio1.43x
    Interest Coverage-699.75x

    Returns and Efficiency

    Return on invested capital is 57.50% over the last 12 months.

    Return on Assets (ROA)-212.54%
    Return on Invested Capital (ROIC)57.50%
    ROA (5Y Average)-93.82%
    Inventory Turnover0.58x
    Receivables Turnover8.42x
    Cash Conversion Cycle-4300 days

    Scores

    ONCO has an Altman Z-Score of -17.04, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-17.04
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Balance Sheet

    Cash and Equivalents$2.74M
    Total Debt$99.25K
    Net Cash$2.64M
    Net Cash Per Share$6.35

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Stock Splits

    The last split was a 1-for-10 reverse split on Nov 6, 2026.

    Last Split DateNov 6, 2026
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 4 similar companies, ONCO has the highest P/S.

    P/S Ratio2.8x vs 0.8x median
    ROIC57.50% vs -61.86% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ONCO

    What is ONCO's market cap?

    Onconetix has a market cap of $2.15M.

    How many shares of ONCO are outstanding?

    Onconetix has 416.12K shares outstanding.

    Does ONCO pay a dividend?

    No. Onconetix does not pay a dividend.

    How much debt does ONCO have?

    Onconetix has $99.25K of total debt and $2.74M of cash and equivalents, a net cash position of $2.64M.